Coronary heart disease
Conditions
Interventions
Treatment Group of coronary heart disease:Conventional Western medicine treatment plus compound danshen dropping pills
Coronary heart disease control group:Conventional Western medicine treatment
Healthy controls:None
Sponsors
Yangjiang People's Hospital
Eligibility
Sex/Gender
All
Age
44 Years to 75 Years
Inclusion criteria
Inclusion criteria: The patients who had been diagnosed coronary heart disease by CAG, and the age was between 35 and 75 years old, do not have exclusion criteria, and voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: (1) patients with respiratory diseases or lung diseases were excluded, (2) patients with liver, kidney and other important organ diseases and malignant tumors were excluded, (3) patients who refused to accept the treatment or were allergic to the drugs used in this study were excluded; (4) the patients with mental disorder or poor treatment compliance were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum lipidomics; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood lipids; | — |
Countries
China
Contacts
Public ContactMeng-liqin
Yangjiang People's Hospital
Outcome results
None listed